| 1 | Lymphoma, AIDS-Related | 37% |
| 2 | Primary Effusion Lymphoma | 37% |
| 3 | Lymphomatoid Granulomatosis | 34.2% |
| 4 | Lymphoma, Follicular | 30.3% |
| 5 | T-Cell Lymphoma | 30.3% |
| 6 | Mantle cell lymphoma | 30.3% |
| 7 | Burkitt Lymphoma | 28% |
| 8 | Hodgkin Disease | 26.4% |
| 9 | Composite Lymphoma | 25.9% |
| 10 | Sezary Syndrome | 21% |
| 11 | Tumor Lysis Syndrome | 19.1% |
| 12 | Lymphoma, T-Cell, Cutaneous | 18.1% |
| 13 | Enteropathy-Associated T-Cell Lymphoma | 18.1% |
| 14 | Autoimmune Lymphoproliferative Syndrome | 16% |
| 15 | Infectious Mononucleosis | 14.7% |
| 16 | Plasmacytoma | 13.9% |
| 17 | Primary amyloidosis | 12.9% |
| 18 | Histiocytic Disorders, Malignant | 12.5% |
| 19 | Mycosis Fungoides | 12% |
| 20 | Lymphomatoid Papulosis | 12% |
| 21 | Heavy Chain Disease | 12% |
| 22 | Sarcoidosis | 11.9% |
| 23 | Agammaglobulinemia | 11.5% |
| 24 | Lymphocele | 11% |
| 25 | Waldenstrom Macroglobulinemia | 10.9% |
| 26 | Multiple Myeloma | 10.9% |
| 27 | Lymphangioleiomyomatosis | 10.6% |
| 28 | Leukemia, T-Cell | 10.3% |
| 29 | Leukemia, B-Cell | 10.3% |
| 30 | leukemia | 10.3% |
| 31 | Neoplasms, Germ Cell and Embryonal | 10.3% |
| 32 | Neoplasms, Glandular and Epithelial | 10.3% |
| 33 | Germ Cell Cancer | 10.3% |
| 34 | Adenitis | 10% |
| 35 | Histiocytosis | 10% |
| 36 | Lymphadenitis | 10% |
| 37 | Lymphangitis | 10% |
| 38 | Lymphedema | 10% |
| 39 | Splenic Diseases | 10% |
| 40 | Thymus Hyperplasia | 10% |
| 41 | Pseudolymphoma | 10% |
| 42 | Lymphadenopathy | 10% |
| 43 | Leukemia, Plasma Cell | 9.8% |
| 44 | Granuloma | 9.7% |
| 45 | Thymus Neoplasms | 9.5% |
| 46 | Paraproteinemias | 9.4% |
| 47 | Lymphoma, Extranodal NK-T-Cell | 8.9% |
| 48 | Neuroectodermal Tumors | 8.7% |
| 49 | Transfusion Reaction | 8.3% |
| 50 | Hypotensive Transfusion Reaction | 8.3% |
| 51 | Lymphatic Abnormalities | 8.2% |
| 52 | Hypergammaglobulinemia | 8% |
| 53 | Thymoma | 7.7% |
| 54 | Neoplasms, Neuroepithelial | 7.6% |
| 55 | Gliomatosis cerebri | 7.6% |
| 56 | Splenic Neoplasms | 6.9% |
| 57 | Hamartoma | 6.9% |
| 58 | Neoplasms, Hormone-Dependent | 6.9% |
| 59 | Neoplasms, Multiple Primary | 6.9% |
| 60 | Paraneoplastic Syndromes | 6.9% |
| 61 | Precancerous Conditions | 6.9% |
| 62 | Neoplasms, Second Primary | 6.9% |
| 63 | Monoclonal Gammopathy of Undetermined Significance | 6.9% |
| 64 | Lymphangiectasis, Intestinal | 6.9% |
| 65 | Autoimmune Diseases | 6.8% |
| 66 | Hypersensitivity | 6.8% |
| 67 | Immunologic Deficiency Syndromes | 6.8% |
| 68 | Immune reconstitution syndrome | 6.8% |
| 69 | Immune Reconstitution Inflammatory Syndrome | 6.8% |
| 70 | Mucocutaneous Lymph Node Syndrome | 6.7% |
| 71 | Carcinosarcoma | 6.7% |
| 72 | Hemangiosarcoma | 6.7% |
| 73 | lymphangiosarcoma | 6.7% |
| 74 | Meningioma | 6.5% |
| 75 | Malignant histiocytosis | 6.5% |
| 76 | Histiocytic sarcoma | 6.5% |
| 77 | Trophoblastic Neoplasms | 6% |
| 78 | melanoma | 6% |
| 79 | Leukemia, Experimental | 6% |
| 80 | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 5.8% |
| 81 | Leukemia, Large Granular Lymphocytic | 5.8% |
| 82 | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 5.8% |
| 83 | Cyst | 5.6% |
| 84 | Neoplastic Processes | 5.6% |
| 85 | Neoplastic Syndromes, Hereditary | 5.6% |
| 86 | Pregnancy Complications, Neoplastic | 5.6% |
| 87 | Hematologic Neoplasms | 5.5% |
| 88 | Neoplasms, Experimental | 5.5% |
| 89 | Carcinoma 256, Walker | 5.5% |
| 90 | Adenoma | 5.4% |
| 91 | Ameloblastoma | 5.4% |
| 92 | Angiokeratoma | 5.4% |
| 93 | Carcinoma | 5.4% |
| 94 | Chordoma | 5.4% |
| 95 | Hemangioma | 5.4% |
| 96 | hemangiopericytoma | 5.4% |
| 97 | Lymphangioma | 5.4% |
| 98 | Mesenchymoma | 5.4% |
| 99 | Nevus | 5.4% |
| 100 | Teratoma | 5.4% |
| 101 | Hepatoblastoma | 5.4% |
| 102 | Mixed Tumor, Mullerian | 5.4% |
| 103 | Germinoma | 5.4% |
| 104 | Teratocarcinoma | 5.4% |
| 105 | Angiofibroma | 5.4% |
| 106 | Sarcoma | 5.4% |
| 107 | Epithelioma | 5.4% |
| 108 | Carcinoma, Ehrlich Tumor | 5.2% |
| 109 | Dermoid Cyst | 5.2% |
| 110 | Carcinoma, Lewis Lung | 5.2% |
| 111 | Leukemia, Radiation-Induced | 5.2% |
| 112 | Elephantiasis | 5.1% |
| 113 | Hypersplenism | 5.1% |
| 114 | Elephantiasis Nostras Verrucosa | 5.1% |
| 115 | Sarcoidosis, Pulmonary | 5% |
| 116 | Basal cell carcinoma | 4.8% |
| 117 | Carcinoma, Papillary | 4.8% |
| 118 | Squamous cell carcinoma | 4.8% |
| 119 | Chondrosarcoma | 4.8% |
| 120 | Craniopharyngioma | 4.8% |
| 121 | Cystadenoma | 4.8% |
| 122 | leiomyosarcoma | 4.8% |
| 123 | liposarcoma | 4.8% |
| 124 | Mesothelioma | 4.8% |
| 125 | synovial sarcoma | 4.8% |
| 126 | Neuroectodermal Tumor, Melanotic | 4.8% |
| 127 | Angiomyolipoma | 4.8% |
| 128 | Clear Cell Sarcoma of Soft Tissue | 4.8% |
| 129 | Alveolar Soft Part Sarcoma | 4.8% |
| 130 | Neuroendocrine Tumors | 4.8% |
| 131 | Sarcoma, Myeloid | 4.8% |
| 132 | Carcinoma, Basal Cell | 4.8% |
| 133 | Neoplasms, Radiation-Induced | 4.6% |
| 134 | Multiple Endocrine Neoplasia | 4.5% |
| 135 | Glomerulonephritis, Membranoproliferative | 4.4% |
| 136 | Melanoma, Experimental | 4.4% |
| 137 | Adenoma, Acidophil | 4.4% |
| 138 | Ganglioneuroma | 4.4% |
| 139 | Glioma | 4.4% |
| 140 | Malignant Glioma | 4.4% |
| 141 | Sarcoma, Experimental | 4.3% |
| 142 | Splenic Infarction | 4.2% |
| 143 | Histiocytosis, Langerhans-Cell | 4.1% |
| 144 | Endometrial Stromal Sarcoma | 4.1% |
| 145 | Thrombocytopenic purpura | 4% |
| 146 | Cryoglobulinemia | 4% |
| 147 | Leukemia L1210 | 3.8% |
| 148 | Leukemia P388 | 3.8% |
| 149 | Acanthoma | 3.8% |
| 150 | Cystadenocarcinoma | 3.8% |
| 151 | Fibrosarcoma | 3.8% |
| 152 | Osteosarcoma | 3.8% |
| 153 | Mucoepidermoid Carcinoma | 3.8% |
| 154 | Choriocarcinoma | 3.8% |
| 155 | Carcinoma, Lobular | 3.8% |
| 156 | Autoimmune thrombocytopenia | 3.7% |
| 157 | Immune thrombocytopenic purpura | 3.7% |
| 158 | Medulloblastoma | 3.7% |
| 159 | Paraneoplastic Encephalomyelitis | 3.6% |
| 160 | Carcinoid Tumor | 3.6% |
| 161 | Neurilemmoma | 3.6% |
| 162 | Hutchinson's Melanotic Freckle | 3.6% |
| 163 | Melanoma, Amelanotic | 3.6% |
| 164 | Tuberous Sclerosis | 3.5% |
| 165 | Mammary Neoplasms, Experimental | 3.5% |
| 166 | Splenic Rupture | 3.5% |
| 167 | Bone Marrow Neoplasms | 3.5% |
| 168 | Nephroblastoma | 3.5% |
| 169 | POEMS Syndrome | 3.4% |
| 170 | Abdominal Neoplasms | 3.4% |
| 171 | Erythroplasia | 3.4% |
| 172 | Follicular cyst | 3.4% |
| 173 | Head and Neck Neoplasms | 3.4% |
| 174 | Mucocele | 3.4% |
| 175 | Pilonidal Cyst | 3.4% |
| 176 | Soft Tissue Neoplasms | 3.4% |
| 177 | Thoracic Neoplasms | 3.4% |
| 178 | Thyroglossal Cyst | 3.4% |
| 179 | Synovial Cyst | 3.4% |
| 180 | Aberrant Crypt Foci | 3.4% |
| 181 | Disseminated Intravascular Coagulation | 3.4% |
| 182 | Protein S Deficiency | 3.4% |
| 183 | Lymphopenia | 3.4% |
| 184 | Transfusion-Related Acute Lung Injury | 3.4% |
| 185 | Anemia | 3.3% |
| 186 | Blood Coagulation Disorders | 3.3% |
| 187 | Blood Platelet Disorders | 3.3% |
| 188 | Bone Marrow Diseases | 3.3% |
| 189 | Hemorrhagic Disorders | 3.3% |
| 190 | Immune Complex Diseases | 3.3% |
| 191 | Leukocyte Disorders | 3.3% |
| 192 | Methemoglobinemia | 3.3% |
| 193 | Pancytopenia | 3.3% |
| 194 | Polycythemia | 3.3% |
| 195 | Sulfhemoglobinemia | 3.3% |
| 196 | Antiphospholipid Syndrome | 3.3% |
| 197 | Thrombophilia | 3.3% |
| 198 | Latex allergy | 3.3% |
| 199 | Erythrocytosis | 3.3% |
| 200 | Adenofibroma | 3.3% |
| 201 | Fibroadenoma | 3.3% |
| 202 | Malignant Fibrous Histiocytoma | 3.3% |
| 203 | Mastocytosis | 3.2% |
| 204 | Leukemia, Myelomonocytic, Chronic | 3.1% |
| 205 | Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative | 3.1% |
| 206 | Retinoblastoma | 3.1% |
| 207 | Adenocarcinoma | 3% |
| 208 | Carcinoma in Situ | 3% |
| 209 | Carcinoma, Transitional Cell | 3% |
| 210 | Phyllodes Tumor | 3% |
| 211 | Dysgerminoma | 3% |
| 212 | Hemangioendothelioma | 3% |
| 213 | Lipoma | 3% |
| 214 | Myoma | 3% |
| 215 | Myxoma | 3% |
| 216 | Neuroma | 3% |
| 217 | Papilloma | 3% |
| 218 | Pseudomyxoma Peritonei | 3% |
| 219 | Seminoma | 3% |
| 220 | Papillomatosis | 3% |
| 221 | Angiolipoma | 3% |
| 222 | Myelolipoma | 3% |
| 223 | Neoplasms, Bone Tissue | 3% |
| 224 | Neoplasms, Fibrous Tissue | 3% |
| 225 | Smooth Muscle Tumor | 3% |
| 226 | Adenomatosis, Pulmonary | 3% |
| 227 | Adenomatous Polyps | 3% |
| 228 | Carcinoma, Large Cell | 3% |
| 229 | Carcinoma, Small Cell | 3% |
| 230 | Desmoplastic Small Round Cell Tumor | 3% |
| 231 | Chondroma | 3% |
| 232 | Enchondroma | 3% |
| 233 | Digestive System Neoplasms | 2.9% |
| 234 | Endocrine Gland Neoplasms | 2.9% |
| 235 | Eye Neoplasms | 2.9% |
| 236 | Nervous System Neoplasms | 2.9% |
| 237 | Sarcoma 180 | 2.9% |
| 238 | Bowen's Disease | 2.8% |
| 239 | Paraganglioma | 2.8% |
| 240 | Rhabdomyosarcoma | 2.8% |
| 241 | Giant Cell Tumor of Bone | 2.8% |
| 242 | Bone neoplasms | 2.8% |
| 243 | Leukoplakia | 2.8% |
| 244 | Pancreatic Cyst | 2.8% |
| 245 | Skin Neoplasms | 2.8% |
| 246 | Environmental Illness | 2.8% |
| 247 | Barrett Esophagus | 2.8% |
| 248 | Breast Cyst | 2.8% |
| 249 | Actinic keratosis | 2.8% |
| 250 | Mediastinal Cyst | 2.8% |
| 251 | Neoplasm Invasiveness | 2.8% |
| 252 | Neoplasm Metastasis | 2.8% |
| 253 | Neoplasm Recurrence, Local | 2.8% |
| 254 | Parovarian Cyst | 2.8% |
| 255 | Pericardial Cyst | 2.8% |
| 256 | Thymic Cyst | 2.8% |
| 257 | Carcinogenesis | 2.8% |
| 258 | Myxoid cyst | 2.8% |
| 259 | Metastasis | 2.8% |
| 260 | Astrocytoma | 2.8% |
| 261 | Ependymoma | 2.8% |
| 262 | oligodendroglioma | 2.8% |
| 263 | Ganglioglioma | 2.8% |
| 264 | gliosarcoma | 2.8% |
| 265 | Anaplastic astrocytoma | 2.8% |
| 266 | Anaplastic Oligodendroglioma | 2.8% |
| 267 | Thrombocythemia, Essential | 2.8% |
| 268 | Lupus Erythematosus, Systemic | 2.7% |
| 269 | Pregnancy Complications, Hematologic | 2.7% |
| 270 | Overlap syndrome | 2.7% |
| 271 | Addison Disease | 2.7% |
| 272 | Pemphigus | 2.7% |
| 273 | Autoimmune thyroiditis | 2.7% |
| 274 | Primary Adrenal Insufficiency | 2.7% |
| 275 | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 2.7% |
| 276 | Autoimmune hepatitis | 2.7% |
| 277 | Lymphohistiocytosis, Hemophagocytic | 2.7% |
| 278 | Schnitzler Syndrome | 2.7% |
| 279 | Erdheim-Chester Disease | 2.7% |
| 280 | Mesoblastic Nephroma | 2.7% |
| 281 | Hemangioma, Cavernous | 2.6% |
| 282 | Basal Cell Nevus Syndrome | 2.6% |
| 283 | Thrombasthenia | 2.5% |
| 284 | Antithrombin III Deficiency | 2.5% |
| 285 | Protein C Deficiency | 2.5% |
| 286 | Neurofibrosarcoma | 2.4% |
| 287 | Dermatofibrosarcoma | 2.4% |
| 288 | Dermatofibrosarcoma Protuberans | 2.4% |
| 289 | Malignant Carcinoid Syndrome | 2.4% |
| 290 | Multiple Endocrine Neoplasia Type 1 | 2.3% |
| 291 | Hepatocellular Adenoma | 2.3% |
| 292 | Corpus Luteum Cyst | 2.3% |
| 293 | Ovarian Cysts | 2.3% |
| 294 | Kernicterus | 2.3% |
| 295 | Vitamin K Deficiency | 2.3% |
| 296 | Latent Autoimmune Diabetes in Adults | 2.3% |
| 297 | Dermatitis Herpetiformis | 2.2% |
| 298 | Kounis Syndrome | 2.2% |
| 299 | Liver Neoplasms, Experimental | 2.2% |
| 300 | HIV Infections | 2.2% |
| 301 | Hydrops Fetalis | 2.2% |
| 302 | Wiskott-Aldrich Syndrome | 2.2% |
| 303 | Mastocytosis, Systemic | 2.1% |
| 304 | Parathyroid Neoplasms | 2.1% |
| 305 | Peritoneal Neoplasms | 2.1% |
| 306 | Thyroid Neoplasm | 2.1% |
| 307 | Thyroid carcinoma | 2.1% |
| 308 | Polycythemia Vera | 2.1% |
| 309 | Thrombocytosis | 2.1% |
| 310 | Job Syndrome | 2.1% |
| 311 | Lambert-Eaton Myasthenic Syndrome | 2% |
| 312 | Sturge-Weber Syndrome | 2% |
| 313 | Afibrinogenemia | 2% |
| 314 | Factor VII Deficiency | 2% |
| 315 | Factor X Deficiency | 2% |
| 316 | Factor XII Deficiency | 2% |
| 317 | Hemophilia A | 2% |
| 318 | Activated Protein C Resistance | 2% |
| 319 | Factor II deficiency | 2% |
| 320 | Factor VIII Deficiency | 2% |
| 321 | Factor V deficiency | 2% |
| 322 | Factor XI Deficiency | 2% |
| 323 | Hypoprothrombinemias | 2% |
| 324 | Carcinoma, Pancreatic Ductal | 2% |
| 325 | Gastrointestinal Stromal Tumors | 2% |
| 326 | Choledochal Cyst | 2% |
| 327 | Prolactinoma | 2% |
| 328 | Growth Hormone-Secreting Pituitary Adenoma | 2% |
| 329 | neurofibroma | 2% |
| 330 | Peutz-Jeghers Syndrome | 2% |
| 331 | Glioblastoma | 2% |
| 332 | Neuroblastoma | 2% |
| 333 | Glioblastoma Multiforme | 2% |
| 334 | Rheumatoid Arthritis | 2% |
| 335 | Juvenile arthritis | 2% |
| 336 | Graves Disease | 1.9% |
| 337 | Anti-Glomerular Basement Membrane Disease | 1.9% |
| 338 | Pheochromocytoma | 1.9% |
| 339 | Alveolar rhabdomyosarcoma | 1.9% |
| 340 | Pancreatic Neoplasm | 1.9% |
| 341 | Adenomatous Polyposis Coli | 1.9% |
| 342 | Hydatidiform Mole | 1.8% |
| 343 | Eosinophilic Granuloma | 1.8% |
| 344 | Leukemia, Myeloid, Chronic-Phase | 1.8% |
| 345 | Splenosis | 1.8% |
| 346 | Retroperitoneal Neoplasms | 1.8% |
| 347 | granulosa cell tumor | 1.8% |
| 348 | Carcinoma, Ovarian Epithelial | 1.8% |
| 349 | Adenoid Cystic Carcinoma | 1.8% |
| 350 | fibroma | 1.8% |
| 351 | Fibromatosis | 1.8% |
| 352 | Osteoblastoma | 1.8% |
| 353 | Osteoma | 1.8% |
| 354 | Rhabdomyoma | 1.8% |
| 355 | Chondromatosis | 1.8% |
| 356 | Adenocarcinoma, Clear Cell | 1.8% |
| 357 | Cholangiocarcinoma | 1.8% |
| 358 | Cervical Intraepithelial Neoplasia | 1.8% |
| 359 | Hemangioblastoma | 1.8% |
| 360 | Acoustic Neuroma | 1.7% |
| 361 | Chronic granulomatous disease | 1.7% |
| 362 | Asthma, Aspirin-Induced | 1.7% |
| 363 | anaphylaxis | 1.7% |
| 364 | Anemia, Hemolytic | 1.7% |
| 365 | Anemia, Macrocytic | 1.7% |
| 366 | Eosinophilia | 1.7% |
| 367 | Food Allergy | 1.7% |
| 368 | Hypoproteinemia | 1.7% |
| 369 | Leukopenia | 1.7% |
| 370 | Thrombocytopenia | 1.7% |
| 371 | Leukostasis | 1.7% |
| 372 | MYELODYSPLASTIC SYNDROME | 1.7% |
| 373 | Anaphylactic shock | 1.7% |
| 374 | Tracheal Neoplasms | 1.6% |
| 375 | Leukoplakia, Oral | 1.6% |
| 376 | Paraneoplastic Cerebellar Degeneration | 1.6% |
| 377 | Optic Nerve Glioma | 1.6% |
| 378 | Ganglioneuroblastoma | 1.6% |
| 379 | Carcinoid Heart Disease | 1.5% |
| 380 | Serum Sickness | 1.5% |
| 381 | Mouth Neoplasms | 1.5% |
| 382 | Central Nervous System Neoplasms | 1.5% |
| 383 | Vascular Neoplasms | 1.5% |
| 384 | Genital Neoplasms, Female | 1.4% |
| 385 | Pancreatic Pseudocyst | 1.4% |
| 386 | Lymphatic Metastasis | 1.4% |
| 387 | Neoplasms, Unknown Primary | 1.4% |
| 388 | Leukemic Infiltration | 1.4% |
| 389 | Breast Neoplasms, Male | 1.4% |
| 390 | Neoplasm Micrometastasis | 1.4% |
| 391 | Triple Negative Breast Neoplasms | 1.4% |
| 392 | Mastocytoma | 1.4% |
| 393 | Vipoma | 1.4% |
| 394 | Hemoglobinuria, Paroxysmal | 1.4% |
| 395 | Leukemoid Reaction | 1.4% |
| 396 | Respiratory Hypersensitivity | 1.4% |
| 397 | Esophageal Neoplasms | 1.4% |
| 398 | Limbic Encephalitis | 1.4% |
| 399 | Anemia, Neonatal | 1.4% |
| 400 | Leukocytosis | 1.4% |
| 401 | Pelger-Huet Anomaly | 1.4% |
| 402 | Sick Building Syndrome | 1.4% |
| 403 | Pleocytosis | 1.4% |
| 404 | Multiple Chemical Sensitivity | 1.4% |
| 405 | Denys-Drash Syndrome | 1.4% |
| 406 | Urticaria | 1.4% |
| 407 | Vasculitis, Leukocytoclastic, Cutaneous | 1.4% |
| 408 | Myelitis, Transverse | 1.4% |
| 409 | Ataxia Telangiectasia | 1.4% |
| 410 | HTLV-I Infections | 1.4% |
| 411 | Nasopharyngeal carcinoma | 1.4% |
| 412 | insulinoma | 1.3% |
| 413 | Testicular Neoplasms | 1.3% |
| 414 | Xeroderma Pigmentosum | 1.3% |
| 415 | Anemia, Sickle Cell | 1.3% |
| 416 | Thalassemia | 1.3% |
| 417 | Purpura, Thrombotic Thrombocytopenic | 1.2% |
| 418 | Adrenal Gland Neoplasms | 1.2% |
| 419 | Gastrointestinal Neoplasms | 1.2% |
| 420 | Genital Neoplasms, Male | 1.2% |
| 421 | Liver neoplasms | 1.2% |
| 422 | Uveal Neoplasms | 1.2% |
| 423 | Urologic Neoplasms | 1.2% |
| 424 | Sebaceous Gland Neoplasms | 1.2% |
| 425 | Spinal Neoplasms | 1.2% |
| 426 | Polycystic Ovary Syndrome | 1.2% |
| 427 | Adrenocortical carcinoma | 1.2% |
| 428 | Fibromatosis, Aggressive | 1.2% |
| 429 | Fibromatosis, Abdominal | 1.2% |
| 430 | Klatskin Tumor | 1.2% |
| 431 | Myasthenia Gravis | 1.2% |
| 432 | Uveomeningoencephalitic Syndrome | 1.2% |
| 433 | Thyroid Nodule | 1.1% |
| 434 | Opsoclonus-Myoclonus Syndrome | 1.1% |
| 435 | Drug Eruptions | 1.1% |
| 436 | Ecchymosis | 1.1% |
| 437 | Petechiae | 1.1% |
| 438 | Purpura | 1.1% |
| 439 | Granulomatosis with polyangiitis | 1.1% |
| 440 | Dermatitis, Allergic Contact | 1.1% |
| 441 | HIV Seropositivity | 1.1% |
| 442 | Leydig Cell Tumor | 1.1% |
| 443 | Anemia, Diamond-Blackfan | 1.1% |
| 444 | Gastrinoma | 1.1% |
| 445 | Glucagonoma | 1.1% |
| 446 | Renal Cell Carcinoma | 1.1% |
| 447 | Papillary Renal Cell Carcinoma | 1.1% |
| 448 | Stiff-Person Syndrome | 1% |
| 449 | Polyradiculoneuropathy | 1% |
| 450 | Polyradiculoneuritis | 1% |
| 451 | Acquired Immunodeficiency Syndrome | 1% |
| 452 | AIDS related complex | 1% |
| 453 | Felty Syndrome | 1% |
| 454 | Lupus Nephritis | 1% |
| 455 | Carcinoma, Endometrioid | 1% |
| 456 | ovarian neoplasm | 0.9% |
| 457 | Purpura, Hyperglobulinemic | 0.9% |
| 458 | Primary Myelofibrosis | 0.9% |
| 459 | Agranulocytosis | 0.9% |
| 460 | Anemia, Megaloblastic | 0.9% |
| 461 | Lymphocytosis | 0.9% |
| 462 | Myelofibrosis | 0.9% |
| 463 | Myeloid Metaplasia | 0.9% |
| 464 | Milk Allergy | 0.9% |
| 465 | Hypoalbuminemia | 0.9% |
| 466 | Wheat Hypersensitivity | 0.9% |
| 467 | Hypereosinophilic syndrome | 0.9% |
| 468 | bone marrow fibrosis | 0.9% |
| 469 | Thrombotic Microangiopathies | 0.9% |
| 470 | AIDS-Related Opportunistic Infections | 0.9% |
| 471 | Vasculitis, Central Nervous System | 0.9% |
| 472 | Waterhouse-Friderichsen Syndrome | 0.9% |
| 473 | Dermatitis, Atopic | 0.9% |
| 474 | HIV Wasting Syndrome | 0.9% |
| 475 | Rheumatoid Vasculitis | 0.9% |
| 476 | AIDS Dementia Complex | 0.9% |
| 477 | AIDS-Associated Nephropathy | 0.9% |
| 478 | Nose Neoplasms | 0.8% |
| 479 | Dupuytren Contracture | 0.8% |
| 480 | Myasthenia Gravis, Autoimmune, Experimental | 0.8% |
| 481 | Meningeal Neoplasms | 0.8% |
| 482 | Urticaria Pigmentosa | 0.8% |
| 483 | Hemolytic-Uremic Syndrome | 0.8% |
| 484 | Pituitary Adenoma | 0.8% |
| 485 | Pituitary Neoplasms | 0.8% |
| 486 | Sicca Syndrome | 0.8% |
| 487 | Sjogren's Syndrome | 0.8% |
| 488 | HIV-Associated Lipodystrophy Syndrome | 0.8% |
| 489 | Lupus Vasculitis, Central Nervous System | 0.7% |
| 490 | Zollinger-Ellison syndrome | 0.7% |
| 491 | Palatal Neoplasms | 0.7% |
| 492 | Ear Neoplasms | 0.7% |
| 493 | Eyelid Neoplasms | 0.7% |
| 494 | Lung Neoplasms | 0.7% |
| 495 | Pleural Neoplasms | 0.7% |
| 496 | Sickle Cell Trait | 0.7% |
| 497 | Cell Transformation, Viral | 0.7% |
| 498 | Brain Neoplasms | 0.7% |
| 499 | Salivary Gland Neoplasms | 0.7% |
| 500 | Spinal Cord Neoplasms | 0.7% |
| 501 | Tongue Neoplasms | 0.7% |
| 502 | Uterine Neoplasms | 0.7% |
| 503 | Vaginal Neoplasms | 0.7% |
| 504 | Vulvar Neoplasms | 0.7% |
| 505 | Uterine Cancer | 0.7% |
| 506 | Fallopian Tube Neoplasms | 0.7% |
| 507 | Eosinophilia-Myalgia Syndrome | 0.6% |
| 508 | Angioedema | 0.6% |
| 509 | Multiple Sclerosis | 0.6% |
| 510 | Shwartzman Phenomenon | 0.6% |
| 511 | Scurvy | 0.6% |
| 512 | Purpura Fulminans | 0.6% |
| 513 | Acute Generalized Exanthematous Pustulosis | 0.6% |
| 514 | Pharyngeal Neoplasms | 0.6% |
| 515 | Central Nervous System Cysts | 0.6% |
| 516 | Bile Duct Neoplasms | 0.6% |
| 517 | gallbladder neoplasm | 0.6% |
| 518 | Intestinal Neoplasms | 0.6% |
| 519 | Penile Neoplasms | 0.6% |
| 520 | Prostatic Neoplasms | 0.6% |
| 521 | Stomach Neoplasms | 0.6% |
| 522 | Fanconi Anemia | 0.6% |
| 523 | Acute Chest Syndrome | 0.5% |
| 524 | Asthma | 0.5% |
| 525 | Laryngeal neoplasm | 0.5% |
| 526 | Encephalomyelitis, Acute Disseminated | 0.5% |
| 527 | Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | 0.5% |
| 528 | Erythema Nodosum | 0.5% |
| 529 | Neuritis, Autoimmune, Experimental | 0.5% |
| 530 | Neuromyelitis Optica | 0.5% |
| 531 | Dermatitis, Photoallergic | 0.5% |
| 532 | Leukoencephalitis, Acute Hemorrhagic | 0.5% |
| 533 | Bladder Neoplasm | 0.5% |
| 534 | Kidney Neoplasm | 0.5% |
| 535 | Ureteral Neoplasms | 0.5% |
| 536 | Urethral Neoplasms | 0.5% |
| 537 | Neutropenia | 0.5% |
| 538 | Meningeal Carcinomatosis | 0.5% |
| 539 | Aspergillosis, Allergic Bronchopulmonary | 0.5% |
| 540 | Guillain-Barre Syndrome | 0.5% |
| 541 | Niemann-Pick Disease, Type C | 0.5% |
| 542 | Atypical Hemolytic Uremic Syndrome | 0.5% |
| 543 | Bronchial Neoplasms | 0.4% |
| 544 | Pulmonary Eosinophilia | 0.4% |
| 545 | Eosinophilic Pneumonia | 0.4% |
| 546 | Toxic Epidermal Necrolysis | 0.4% |
| 547 | Stevens-Johnson Syndrome | 0.4% |
| 548 | Multiple Pulmonary Nodules | 0.4% |
| 549 | Supratentorial Neoplasms | 0.4% |
| 550 | Endometrial Neoplasms | 0.4% |
| 551 | Anemia, Pernicious | 0.4% |
| 552 | Pseudoxanthoma Elasticum | 0.4% |
| 553 | Giant Cell Arteritis | 0.4% |
| 554 | Temporal Arteritis | 0.4% |
| 555 | Hypopharyngeal Neoplasms | 0.3% |
| 556 | Pleural Effusion, Malignant | 0.3% |
| 557 | Hypopharyngeal Cancer | 0.3% |
| 558 | Parotid Neoplasms | 0.3% |
| 559 | Prostatic Neoplasms, Castration-Resistant | 0.3% |
| 560 | Nelson Syndrome | 0.3% |
| 561 | Asthma, Exercise-Induced | 0.3% |
| 562 | Status Asthmaticus | 0.3% |
| 563 | Multiple Sclerosis, Chronic Progressive | 0.3% |
| 564 | Multiple Sclerosis, Relapsing-Remitting | 0.3% |
| 565 | Cecal Neoplasms | 0.3% |
| 566 | Duodenal Neoplasms | 0.3% |
| 567 | Asthma, Occupational | 0.3% |
| 568 | Febrile Neutropenia | 0.3% |
| 569 | Farmer's Lung | 0.3% |
| 570 | Angioedemas, Hereditary | 0.3% |
| 571 | Hay fever | 0.3% |
| 572 | Rhinitis, Allergic, Perennial | 0.3% |
| 573 | Nasopharyngeal Neoplasms | 0.3% |
| 574 | Colorectal Neoplasms | 0.3% |
| 575 | Brain Stem Neoplasms | 0.3% |
| 576 | Paranasal Sinus Neoplasms | 0.2% |
| 577 | Tonsillar Neoplasms | 0.2% |
| 578 | Cerebellar Neoplasms | 0.2% |
| 579 | Radicular Cyst | 0.2% |
| 580 | Appendiceal Neoplasms | 0.2% |
| 581 | Colonic Neoplasms | 0.2% |
| 582 | Rectal Neoplasms | 0.2% |
| 583 | Hereditary Angioedema Type III | 0.2% |
| 584 | Hereditary Angioedema Types I and II | 0.2% |
| 585 | Choroid Plexus Papilloma | 0.2% |
| 586 | Miller Fisher Syndrome | 0.2% |
| 587 | Maxillary Sinus Neoplasms | 0.2% |
| 588 | Anus Neoplasms | 0.1% |
| 589 | Sigmoid Neoplasms | 0.1% |